Sponsor or Organizer: GTC Bio

Description: Metabolic disorders have become a major social problem in the US and around the world playing key roles in many diseases such as obesity, diabetes, cardiovascular disease, inflammatory disease and cancer. Over the past few years, pharmaceutical and biotech companies have invested a substantial amount of time and money to battle metabolic diseases. This conference will cover many important aspects of metabolic related drug discovery and development including successful stories of metabolic disease related drugs, the progress of potential drugs in pre-clinical or clinical trials, and R&D activities of Big Pharma and Biotechs. This conference will also provide an interactive network between academia and the private sector at multiple levels including Big pharma, large/mid-cap and small-cap biotechs, and investors. The following topics will be covered:

-Obesity Epidemic -Current Strategies for the Treatment of Obesity -Regulating Energy Homeostasis -Cross Talks Between Obesity, Vascular Diseases, Inflammatory Diseases and Cancer -Novel Targets for Obesity and Diabetes -Predictive Animal Models -Preclinical and Clinical Trials, and Challenges -Receptors, Kinases, and Modulators -Metabolomic Profiling for Discovery and Development -Food Intake, Nutrition and Appetite

Dates: 06/29/2005

Location: San Francisco, CA, USA